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Introduction 
6-Pyruvoyl tetrahydropterin synthase (PTP synthase) 
is one of the key enzymes in the biosynthetic pathway 
of tetrahydrobiopterin (BH4) (1), the natural cofactor 
of the mammalian aromatic amino acid hydroxylases 
(2). PTP synthase deficiency is the most common and 
heterogeneous genetic disease in BH4 metabolism. 
Analysis of urinary pterins combined with the meas-
urement of enzyme activity in red blood cells, as well 
as analysis of metabolites in CSF enables differentia-
tion between the variants of PTP synthase deficiency. 
In this paper we describe the use of specific mono-
clonal antibodies prepared against human piutitary 
gland PTP synthase for the immunocytochemical lo-
calization of the enzyme in bone marrow smears, 
different cell lines, human cultured skin and amniotic 
fluid fibroblasts, as well as in human and mouse 
macrophages. We also report the quantification of 
PTP synthase activity in extracts of the above men-
tioned cells. 
Utilizing specific anti-PTP synthase monoclonal an-
tibodies and an enzyme assay based on the quantifi-
cation of biopterin using fluorescence detection, am-
niotic fluid fibroblasts may be suitable for prenatal 
diagnosis of PTP synthase deficiency. 
Material and Methods 
Pteridines and other chemicals as well as tissue culture 
mediums were obtained as previously described (3). 
In vitro immunization and subcloning by limited dilu-
tion 
Monoclonal antibodies were produced using the in 
vitro immunization technique with the antigen blotted 
from SDS-PAGE to Immobilon polyvinylidene di-
fluoride (PVDF) membranes (Guzman et al. submit-
ted). PTP synthase partially purified from human 
pituitary gland was used as antigen. Fusion, cell cul-
ture, HAT selection and cell cloning by limited dilu-
tion were done as reported previously (3). 
The enzyme linked immunosorbent assay (ELISA) 
test for specific antibodies was performed according 
to standard procedures with slight modifications. 
PTP synthase assay 
The PTP synthase activity assay was performed as 
described previously (4), except for the incubation 
time, which was reduced to 20 minutes. One unit of 
enzyme activity catalyses the production of 1 μηιοί 
BH4/min from dihydroneopterin triphosphate 
(NH2TP) at 37 °C under standard conditions. 
" Author to whom correspondence should be addressed 
Abbreviations: BH4, tetrahydrobiopterin; PTP synthase, 6-py-
ruvoyl tetrahydropterin synthase; ELISA, enzyme linked im-
munosorbent assay; PVDF. polyvinylidene difluoride; HAT, 
hypoxanthine, aminopterin, thymidine; NI-LTP, dihydroneop-
terin triphosphate; APAAP, alkaline phosphatase monoclonal 
anti-alkaline phosphatase complex; LPS, lipopolysaccharide. 
Tissue culture 
The human transitional cell bladder carcinoma line 
Τ 24 (obtained from Dr. E. Werner, Institute for Med-
ical Chemistry and Biochemistry, University of Inns-
bruck, Austria), human skin fibroblasts and the hu-
man neuroblastoma cell line SK-N-BE were cultured 
in minimum essential medium supplemented with 
Pteridines / Vol.3/ No. 1/2 
Copyright © 1992 Walter de Gruyter • Berlin • New York 
44 Guzman and Blau: 6-pyrovoyl tetrahydropterin synthase in human tissues and cells lines 
10% heat-inactivated fetal calf serum, 2 mM L-glu-
tamine, 100 units/ml penicillin and 0.1 ng/ml stepto-
mycin. The pituitary cell line GH4C1 (obtained from 
Dr. W. Schlegel, Fondation pour Recherches Médical, 
Université de Genève, Switzerland), a subclone from 
the cell line GH3, was cultured in Nutricn mixture Ρ-
ΙΟ (HAM) supplemented with 2.5% fetal calf serum 
and 15% (Donor) horse serum. The human Burkitt 
lymphoma cell lines BJA-B and Namalwa (obtained 
from Dr. E. Schreiber, Department of Clinical Im-
munology, University Hospital, Zürich, Switzerland) 
were grown in RPMI 1640 medium supplemented 
with 10% heat-inactivated fetal calf serum, 2 mM L-
glutamine, 100 units/ml penicillin, 0.1 ng/ml strepto-
mycin and 50 μΜ 2-mercaptoethanol. 
Human and mouse macrophages were generously sup-
plied by Dr. A. Schaffner (Department of Internal 
Medicine, University Hospital, Ziirich, Switzerland). 
The PTP synthase activity was measured in the cytosol 
fractions of mouse peritoneal macrophages and 
monocytes purified from human peripheral blood 
(99% purified). 
Preparation of the cell extracts 
Adherent cells were detached by trypsin (0.5 mg/ml) 
in phosphate-buffered saline (PBS, pH 7.4) and 
washed 3 times with Hanks' balanced salt solution. 
Cells were then suspended in 600—1000 μΐ of 5 mM 
Tris/HCl, pH 7.4, and disrupted by freezing and thaw-
ing. After centrifugation at 12 000 g for 15 minutes, 
50 μΐ of the supernatant were used for the PTP syn-
thase activity assay. The non-adherent cell lines were 
washed 3 times with Hanks' balanced salt solution 
and then disrupted as described above. 
Preparation of the cell smears 
Bone marrow smears were routinely prepared from 
healthy controls. Adherent cells such as skin fibro-
blasts and other above mentioned cell lines were cul-
tured in Nunc Slide Flasks for 4 days. Non-adherent 
cells were cytocentrifuged. The slides were washed 
twice with Hanks' balanced salt solution and then air 
dried overnight. All smears were stored at —20 °C, 
protected from humidity, or directly used for the 
immunocytochemical localization of the enzyme. 
Cytocentrifuged smears of the THP-1 myelomono-
cytoma cell line were obtained from Dr. G. Werner-
Feldmayer (Institute for Medical Chemistry and Bio-
chemistry, University of Innsbruck, Austria). 
Immunoenzymatic staining of PTP synthase 
The slides were fixed for 1 minute in acetone/methanol 
1 : 1 and then processed as described (3), using anti-
PTP synthase monoclonal antibodies and the alkaline 
phosphatase/monoclonal anti-alkaline phosphatase 
labeling technique (APAAP) (5). Positive and negative 
controls for the immunostaining of the cell smears 
were the same as reported previously (3). As positive 
control for the human cultured macrophages and for 
the THP-1 cell line, a monoclonal antibody to a 
surface antigen from monocytes was used. The neg-
ative control was the same as for the above mentioned 
cell smears. 
Results and Discussion 
In contrast to previous results (6) we were now able 
to measure PTP synthase activity in human macro-
phages (0.2 μυ /mg protein). These results arc higher 
than those reported by Werner et al. (7) (0.1 μυ /mg 
protein). However, even higher PTP synthase activity 
(0.4 μυ /mg protein) was obtained by Dr. Shintaku in 
our department (unpublished data). No enhancement 
of activity was found when human macrophages were 
stimulated with lipopolysaccharide (LPS) (data not 
shown). With the mouse macrophages, a 2-fold higher 
PTP synthase activity was found. Surprisingly, very 
intense staining was found in human macrophages 
with the monoclonal antibody 16G6 as compared with 
cell lines that showed higher PTP synthase activity. 
Similar strong staining of PTP synthase with mono-
clonal antibody 16G6 was found in the bone marrow 
smears of healthy donors. 
As previously reported (3), the cytosol of skin fibro-
blasts is uniformly stained for PTP synthase and very 
intense staining of the cytoplasm of dividing fibro-
blasts was observed. We further investigated PTP 
synthase activity in fibroblasts after disruption by 
freezing and thawing. A PTP synthase activity of 
4 μυ /mg protein was found. The lack of PTP synthase 
activity described earlier (8) was due to incomplete 
lysis of the cells, rather than to sensitivity problems. 
We also observed an enhancement of activity when 
the cclls were incubated for 15 min with 1% Triton-
X-100 in 5 mM Tris/HCl, pH 7.4, at 4 C. It is not yet 
clear if this enhancement is due to better disruption 
of the cells or if the PTP synthase is also membrane 
bound. 
As shown in Table 1 high STP synthase activity was 
found in the neuroblastoma cell line SK-N-BE (24.3/ 
23.8 μυ /mg protein), in the Burkitt lymphoma cell 
line BJA-B (32/31.4 μυ/mg protein), in the human Τ 
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Table 1. PTP synthase activity in different cells. 
Cells Activity Ref. η 
μ υ / m g protein 
SK-N-BE 24.3/23.8 2 
BJA-B 32.0/31.4 2 
GH4C1 38.6 1 
Namalwa n .d . 5 
Molt-4 48.0 1 
THP-1 0.397 + 0.036 7 5 
0.349 + 0.055* 7 5 
T-24 7.63 + 0.77 7 5 
7.86 + 0.34* 7 5 
Fibroblasts 4.0 ± 0.12 7 
Macrophages 
human 0.2** 1 
mouse 0.4** 1 
One unit of enzyme activity catalyses the production of 1 μπιοί 
BHí/min from N H ? T P at 37 "C under standard conditions. 
* Treatment of the cells with I FN gamma 
** No difference was observed after treatment with LPS 
n. d. = not detected 
cell leukemia line Molt 4 (48 μΙΙ/mg protein) as well 
as in the pituitary gland cell line GH4C1 (38.6 μΐJ/ 
mg protein). Surprisingly we did not find PTP syn-
thase activity in the Namalwa cell line (another Burk-
itt lymphoma cell line). 
The cross reactivity of the 16G6 and 7F8 antibodies 
with PTP synthase in those cell lines was also inves-
tigated. As expected, the cells presented uniform stain-
ing for PTP synthase and no unspecific staining with 
the negative control was found. 
With cytocentrifuged smears of the cell lines Τ 24, 
Molt 4, and THP-1, uniform staining for PTP syn-
thase with monoclonal antibody 16G6 was also ob-
served. PTP synthase activity in the Τ 24 and THP-1 
cell lines has already been reported by Werner et al. 
in 1990 (7). 
Prenatal diagnosis of PTP synthase deficiency has 
been routinely performed by the measurement of pter-
idines in amniotic fluid and PTP synthase activity in 
fetal blood. 
As reported previously for blood smears (5), very 
heterogeneous weak labeling for PTP synthase was 
found in erythrocytes while reticulocytes were clearly 
and intensively stained. We also demonstrated that 
T-lymphocytcs and granulocytes presented intense 
and clear staining for PTP synthase. Because of the 
variable cell counts for white cells, reticulocytes and 
young erythrocytes, the range of PTP synthas activity 
has relatively great variability. Furthermore, fetos-
copy can be performed only in specialized hospitals 
and may be a risk for the fetus. 
In one effort to develop a suitable assay for prenatal 
diagnosis of PTP synthase deficiency, we measured 
PTP synthase activity in the amniotic fluid cells of 
four healthy donors (kindly supplied by Dr. Binkert, 
Department of Medical Genetics, University of Zü-
rich, Switzerland). We were able to detect PTP syn-
thase activity in cultured amniotic cclls (data not 
shown). Therefore, measurement of PTP synthase ac-
tivity in cultured amniotic fluid fibroblasts may offer 
a possibility for prenatal diagnosis of PTP synthase 
deficiency in pregnancies at risk. Since immunocyto-
chemistry is much more sensitive than fluorometric 
detection of biopterin, we plan to visualize PTP syn-
thase in uncultured and cultured amniotic cells of 
healthy donors. 
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